UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000031289
Receipt No. R000035720
Scientific Title The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy.
Date of disclosure of the study information 2018/02/13
Last modified on 2020/08/18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy.
Acronym The analysis of new parameters in serum samples of UC patients.
Scientific Title The analysis of new chemical parameter in blood samples of active Ulcerative Colitis patients by Raman scattering spectroscopy.
Scientific Title:Acronym The analysis of new parameters in serum samples of UC patients.
Region
Japan

Condition
Condition Ulcerative Colitis
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To identify potential serologic biomarkers for assessing UC activity and monitoring efficacy of treatment
Basic objectives2 Others
Basic objectives -Others biochemical examination
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1:Try to identify molecules that could correlate with endoscopic findings(UC-EIS) before treatment and at 10 weeks on therapy.
2:To test whether a novel biomarker could be used to predict mucosal healing at 1 year after treatment initiation.
Key secondary outcomes 1:To evaluate the correlation between the new biomarker(s) and UCDAI score at 1,4,10 weeks and 1year after treatment.
2:To evaluate the correlation between the new biomarker(s) and Matts grade at 10 weeks after treatment.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who have received complete information about the study and are willing to provide written informed consent.
Key exclusion criteria 1:Inability or unwillingness of patients to give written informed consent
2:Judged unsuitable for this study by the physician
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Akiko
Middle name
Last name Toshimori
Organization Showa University Koto Toyosu Hospital
Division name Digestive Disease Center
Zip code 1358577
Address 5-1-38 Toyosu Koto-ku, Tokyo, Japan
TEL 03-6204-6000
Email akikotoshimori@med.showa-u.ac.jp

Public contact
Name of contact person
1st name Akiko
Middle name
Last name Toshimori
Organization Showa University Koto Toyosu Hospital
Division name Digestive Disease Center
Zip code 1358577
Address 5-1-38 Toyosu Koto-ku, Tokyo, Japan
TEL 03-6204-6000
Homepage URL
Email akikotoshimori@med.showa-u.ac.jp

Sponsor
Institute Showa University Koto Toyosu Hospital
Institute
Department

Funding Source
Organization Showa University Koto Toyosu Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Showa University Koto Toyosu Hospital
Address 5-1-38, Toyosu, Koto-ku, Tokyo, Japan
Tel 0362046000
Email th_irb@ofc.showa-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2017 Year 12 Month 07 Day
Date of IRB
Anticipated trial start date
2018 Year 01 Month 31 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information discribed in the "Assesment" column

Management information
Registered date
2018 Year 02 Month 13 Day
Last modified on
2020 Year 08 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035720

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.